Oxford Drug Design
Biotechnology company with a proprietary computational and machine learning platform
Oxford Drug Design has raised €2.6M across 1 funding round from 4 investors, most recently a round in May 2022. Based in Oxford, UK; active in Healthtech. Data as of 28 Oct 2026.
Oxford, UKwww.oxforddrugdesign.com ↗
Total raised
€2.6M
€2,596,544
Funding rounds
1
Investors
4
distinct backers
Active since
2022-05
latest 2022-05
Funding by year
EUR raised per yearOxford Drug Design — funding by year — interactive chart.
Data table
| Oxford Drug Design — funding by year | |
|---|---|
| 2022 | €2.6M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-05-19 | Other | €2.6M | ACF investors,Meltwind Advisory LLP,o2h Ventures,R42 Group | View deal → |
Related news
- Cancer-fighting spinout Oxford Drug Design raises £2.2mbusinesscloud.co.uk · 2022-05
Similar companies
same sector or countryGlobal coverage: FundingData